U.S. President Donald Trump has withdrawn the nomination of Joel Rayburn, his former envoy for Syria, to serve as assistant secretary of state for Near Eastern affairs, according to two sources familiar with the decision. Rayburn, who played a prominent role in Middle East policy during Trump’s first term, was nominated in February to oversee U.S. diplomatic efforts in the region.
The Senate Foreign Relations Committee held a confirmation hearing in May, but Rayburn’s nomination faced opposition from both sides of the aisle. Republican Senator Rand Paul and committee Democrats reportedly raised concerns about Rayburn’s record and his role in Trump’s Syria policy. Last week, the committee took the rare step of advancing his nomination without formally recommending it to the full Senate—a signal that he lacked sufficient support for confirmation.
Sources said the administration decided to withdraw the nomination after determining that Rayburn did not have the votes needed to move forward. The White House has not yet issued an official statement, and Axios was the first to report the withdrawal.
During his confirmation hearing, senators questioned Rayburn about allegations that U.S. officials had been misled regarding the number of American troops stationed in Syria during Trump’s presidency. Rayburn firmly denied any involvement in such actions, stating he played no part in misleading officials or the public.
Rayburn previously served in senior positions at the State Department and the National Security Council, where he was a key figure in shaping Trump’s Middle East strategy. The withdrawal of his nomination marks another setback in the administration’s efforts to fill senior diplomatic roles as it continues to redefine U.S. policy in the region.


Pentagon Ends Military Education Programs With Harvard University
New York Legalizes Medical Aid in Dying for Terminally Ill Patients
U.S. Announces Additional $6 Million in Humanitarian Aid to Cuba Amid Oil Sanctions and Fuel Shortages
TrumpRx Website Launches to Offer Discounted Prescription Drugs for Cash-Paying Americans
U.S. to Begin Paying UN Dues as Financial Crisis Spurs Push for Reforms
Nighttime Shelling Causes Serious Damage in Russia’s Belgorod Region Near Ukraine Border
Iran–U.S. Nuclear Talks in Oman Face Major Hurdles Amid Rising Regional Tensions
Jack Lang Resigns as Head of Arab World Institute Amid Epstein Controversy
Trump Endorses Japan’s Sanae Takaichi Ahead of Crucial Election Amid Market and China Tensions
Trump Signs Executive Order Threatening 25% Tariffs on Countries Trading With Iran
Ohio Man Indicted for Alleged Threat Against Vice President JD Vance, Faces Additional Federal Charges
Federal Judge Restores Funding for Gateway Rail Tunnel Project
Trump Says “Very Good Talks” Underway on Russia-Ukraine War as Peace Efforts Continue
U.S. Lawmakers to Review Unredacted Jeffrey Epstein DOJ Files Starting Monday
Netanyahu to Meet Trump in Washington as Iran Nuclear Talks Intensify
TrumpRx.gov Highlights GLP-1 Drug Discounts but Offers Limited Savings for Most Americans 



